NIH-funded research R01 grant

Improving treatment for people with HIV who smoke and drink alcohol in Kenya

Official title: Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol use among PWH in Nairobi, Kenya

Funded at University of Chicago · NIH-11007953 · Data updated 2026-11-12

This study is looking for ways to help people living with HIV in Nairobi, Kenya, cut down or quit smoking and drinking alcohol by combining counseling and medication, so they can live healthier lives and lower their risk of serious diseases.

More Alcohol Use research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 18, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$728,006
NIH project number1R01CA288235-01A1
Project IDNIH-11007953 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV in Nairobi who also engage in smoking and unhealthy alcohol use.

Less likely to help

Patients who do not smoke or consume alcohol may not receive direct benefits from this research.

What this research studies

This research focuses on addressing the high rates of tobacco and alcohol use among people living with HIV (PWH) in Nairobi, Kenya. It aims to develop and optimize treatment strategies that combine behavioral counseling with medication to help individuals reduce or quit smoking and unhealthy alcohol consumption. The study utilizes a randomized controlled trial design to evaluate the effectiveness of these combined interventions, which have been tailored specifically for the unique challenges faced by PWH in this region. By understanding the interplay between tobacco and alcohol use, the research seeks to improve health outcomes and reduce the risk of related diseases, such as esophageal cancer.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatment options for PWH, ultimately improving their overall health and quality of life.

How similar studies have gone: Previous research has shown promising results in addressing co-occurring substance use among PWH, indicating that this approach has potential for success.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Himelhoch, Seth S — University of Chicago
  • Study coordinator: Himelhoch, Seth S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.